Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesReimbursement/Payment PolicySummaCare Radiopharmaceutical Policy Update | Open…
    Ask Trek AI about this page
    CurrentSummaCarePolicy CSCL0037

    Radiopharmaceuticals

    Customize your policy alerts

    Sign up for summacare Policy CSCL0037 alerts

    Get alerted when Policy CSCL0037 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs SummaCare reimbursement for radiopharmaceuticals and contrast material used in office and outpatient settings, subject to member benefits, provider agreements, claim edits, medical necessity, and prior authorization requirements.

    Policy Summary
    PayerSummaCare
    PolicyRadiopharmaceuticals
    Policy CodePolicy CSCL0037
    Change TypePolicy update
    Effective DateN/A
    Last ReviewSep 26, 2022
    Next Review DateN/A
    Key ActionProviders must account for prior authorization requirements when determining reimbursement.
    SourceLink
    POLICY UPDATE CHANGES

    The policy revision added an update related to HCPCS code A9500.

    3Bundled-payment denial contexts
    10 yearsDocumentation retention
    4Applicable entities
    5Applicable business lines

    Reimbursement Coverage and Bundling Rules

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Radiopharmaceutical reimbursement and bundling exclusions

    Reimbursed when all of the following conditions are met, subject to the listed bundling exclusions:

    ALL of the following

    • Radiopharmaceutical diagnostic imaging isotope or agent is used.
    • The isotope or agent is used in a diagnostic nuclear medicine procedure.
    • None of the following exclusions apply

      • Contrast agent is billed with an MRI.
      • Radiopharmaceutical is billed with a PET scan.
      • Material is billed with a CT or other radiographic study.

    Services subject to included-in-primary-service denial

    The following billed items are denied as included in reimbursement for the primary service:

    Any of the following applies

    • Contrast agent billed with an MRI.

      Denied as included in reimbursement for the primary service.

    • Radiopharmaceutical billed with a PET scan.

      Denied as included in reimbursement for the primary service.

    • Material billed with a CT or other radiographic study.

      Denied as included in reimbursement for the primary service.

    General payment limitations

    Payment determination is also subject to all of the following conditions:

    ALL of the following

    • Member plan benefits apply.
    • The provider participation agreement applies.
    • Routine claim-editing logic applies, including incidental or mutually exclusive logic.
    • Applicable medical-necessity requirements are met.
    • Applicable prior authorization requirements are met.

    Referenced Code Update

    Referenced code updateHCPCS
    A9500Code referenced as having an update in the 2022 revision; the document provides no further description.

    Billing and Reimbursement Responsibilities

    Prior Authorization

    Apply prior authorization requirements

    Account for applicable prior authorization requirements when determining reimbursement. Payment is subject to the plan’s prior authorization requirements.

    Billing Rule

    Use appropriate utilization and billing practices

    Submit claims based on industry trends and appropriate utilization and billing practices for the office setting and outpatient places of service.

    Denial Risk

    Account for payment limitations and claim edits

    Determine payment with applicable limitations in mind. Reimbursement is subject to member plan benefits, the provider participation agreement, routine claim-editing logic—including incidental or mutually exclusive logic—and medical necessity.

    Policy Summary
    PayerSummaCare
    PolicyRadiopharmaceuticals
    Policy CodePolicy CSCL0037
    Change TypePolicy update
    Effective DateN/A
    Last ReviewSep 26, 2022
    Next Review DateN/A
    Key ActionProviders must account for prior authorization requirements when determining reimbursement.
    SourceLink
    On This Page
    Reimbursement Coverage and Bundling RulesReferenced Code UpdateBilling and Reimbursement Responsibilities